Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,368.00
Bid: 2,357.00
Ask: 2,358.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.042%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 2,368.00
HLMA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

27 Sep 2018 07:00

RNS Number : 0655C
Halma PLC
27 September 2018
 

 

Halma plc

 

Trading Update

 

27 September 2018

 

 

Halma, the leading safety, health and environmental technology group, today releases its scheduled trading update, for the period from 1 April 2018 to date.

 

Halma made good progress in this period, in line with the Board's expectations.

 

All sectors delivered organic constant currency revenue and profit growth. Order intake was ahead of revenue and also ahead of the same period last year.

 

The Medical and Environmental & Analysis sectors delivered strong growth, with Medical continuing to benefit from the actions taken to improve profitability in the second half of last year. Process Safety and Infrastructure Safety continued to perform well, even though the Process Safety performance included some modest re-organisation costs.

 

There was widespread growth geographically, with organic constant currency revenue increases in all major regions. The USA grew strongly, and all other regions saw good rates of growth.

 

Cash generation remained strong. This, together with Halma's robust financial position, will support continued investment in growth, both organically and by acquisition.

 

We have a good acquisition pipeline and our M&A teams continue to be active. We made three small, technologically-driven bolt-on acquisitions in the period, for a maximum total consideration of £3 million.

 

The results for the half year ending 30 September 2018 will be released on 20 November 2018.

 

For further information, please contact:

 

 

Halma plc

 

Andrew Williams, Chief Executive

On 27 September: +44 (0)7776 685948

Marc Ronchetti, Chief Financial Officer

Thereafter: +44 (0)1494 721111

Charles King, Head of Investor Relations

 

 

MHP Communications

 

Rachel Hirst/ Andrew Jaques

+44 (0)20 3128 8100

 

 

 

About Halma

 

Halma is a market leader in specialist safety, health and environmental technologies, creating a safer, cleaner and healthier future for people worldwide. We target markets where sustainable growth and high returns are supported by long-term drivers. We operate in four sectors: Process Safety, Infrastructure Safety, Medical and Environmental & Analysis. We employ over 6,000 people in 20 countries, with major operations in Europe, the USA and Asia-Pacific. In the year to 31 March 2018, the Group's revenues exceeded £1bn for the first time. Halma is listed on the London Stock Exchange and has been a member of the FTSE 100 index since December 2017.

 

Notes:

 

1. This Trading Update is based upon unaudited management accounts information. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

2. The Medical sector disposed of the Accudynamics fluid technology business for US$5m, resulting in a small loss on disposal of US$1.6m. The original US$31.8m consideration on acquisition in Dec 2010 primarily related to goodwill (regarding our, ultimately successful, ability to develop the product offering of other fluid technology businesses across the Halma group) and customer intangibles.

 

3. The Finance Director succession was completed as planned in the period, with Marc Ronchetti starting as Halma's Chief Financial Officer on 1 July 2018, following an extensive handover process. In other senior moves, Carol Chesney, Company Secretary, will leave Halma after 23 years at the end of September 2018 to focus on her non-executive appointments, with a new General Counsel and Company Secretary expected to be appointed in early 2019, and Charles King joined as Head of Investor Relations earlier this month.

4. A copy of this announcement, together with other information about Halma, may be viewed on its website at www.halma.com

Ends

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTBUGDCSUDBGIL
Date   Source Headline
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change
30th Nov 20235:28 pmRNSPDMR Shareholding
22nd Nov 20234:36 pmRNSDirector Declaration
20th Nov 20237:00 amRNSAcquisition
16th Nov 20237:00 amRNSHalf Year Results
25th Oct 20237:00 amRNSAcquisitions
3rd Oct 202310:50 amRNSDirector/PDMR Shareholding
27th Sep 202312:28 pmRNSHolding(s) in Company
25th Sep 20231:00 pmRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSTrading Update
4th Aug 20237:00 amRNSAcquisition
31st Jul 20233:00 pmRNSDirector/PDMR Shareholding
24th Jul 20239:00 amRNSDirectorate Change
20th Jul 20233:51 pmRNSResult of AGM
30th Jun 20239:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20233:58 pmRNSAnnual Financial Report
15th Jun 20237:00 amRNSFull Year Results
30th May 20237:11 amRNSDirector Declaration
12th May 20238:00 amRNSCompletion of acquisition
5th May 20237:00 amRNSAcquisition
28th Mar 20237:00 amRNSAcquisition
16th Mar 20237:00 amRNSTrading update
1st Mar 20233:39 pmRNSDirector/PDMR Shareholding
1st Feb 20237:00 amRNSAcquisition
12th Jan 20237:00 amRNS2022 AGM – Voting Results Update Statement
29th Nov 202212:42 pmRNSDirector/PDMR Shareholding
17th Nov 20227:00 amRNSHalf Year Results
11th Nov 20227:00 amRNSHalma appoints new Chief Financial Officer
6th Oct 20227:00 amRNSAcquisition
3rd Oct 20224:38 pmRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAcquisition
22nd Sep 20227:00 amRNSTrading Statement
28th Jul 20223:01 pmRNSDirector/PDMR Shareholding
21st Jul 20223:33 pmRNSResult of AGM
4th Jul 20223:38 pmRNSDirector/PDMR Shareholding
29th Jun 20229:54 amRNSDirector/PDMR Shareholding
23rd Jun 20225:50 pmRNSAnnual Financial Report
17th Jun 20224:41 pmRNSDirector/PDMR Shareholding
16th Jun 20227:01 amRNSGroup Chief Executive succession
16th Jun 20227:00 amRNSFinal Results
14th Apr 20227:00 amRNSAcquisition
7th Apr 20227:00 amRNSSite Visit
28th Mar 20221:59 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSTrading update
21st Feb 20227:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.